Miltenyi Biotec Company Fact Sheet

About
Miltenyi Biotec is the world’s leading innovator in cellular research and its translation into clinical
application. Our mission is to improve scientific understanding and medical progress by providing
solutions that advance biomedical research and cellular therapy. We are committed to bringing
smarter technologies to leading researchers and clinicians.

Fast facts
 Founded in 1989 by Stefan Miltenyi in Germany
 Over 1,300 employees in 22 countries
 Distribution to 34 additional countries
 Over 4,500 products manufactured and distributed worldwide
 FDA approval for the CliniMACS® CD34 Reagent System – the world’s only
US FDA-approved cell therapy device
 Wide variety of CE-marked reagents for the CliniMACS Platform

Key competencies
Leading the industry with the deepest R&D pipeline for cellular research and cellular therapy,
the company applies world-renowned German engineering, design, and quality standards to
meet customer needs.
 In-house production lines for all instruments, consumables, and reagents
 State-of-the-art GMP and contract manufacturing facility in Teterow, Germany
 Quality certified (ISO 9001 and ISO 13485) for the highest possible levels of consistency
in our products
 Making cell therapy a reality through the development of robust cell processing and
manufacturing technologies
 Partnering with customers to advance science and cellular therapies
 Offering the most comprehensive portfolio for transforming basic research into clinical application
 Global regulatory operations with sponsored registration studies and 20 Type II Master files at the
FDA, which enable roughly 200 investigator-sponsored clinical studies in the U.S.

Major brands
MACS® Technology: Since 1990 the MACS brand has fulfilled customer demands to access,
analyze, and utilize primary cells leading to the world’s most cited technology for cell isolation.

MACS® Solutions: Miltenyi Biotec provides integrated technologies for cell isolation,
sample preparation, cell separation, flow cytomtery, cell culture, and molecular analysis.
CliniMACS® System: Based on magnetic cell sorting technology, the CliniMACS System platform allows
the operator to perform clinical-scale magnetic enrichment of target cells, or depletion of unwanted
cells, in a closed and sterile system. It enables the discovery of novel cellular therapies and translates
research into practical clinical applications.

MACS® GMP Products: The MACS GMP Product line is the brand of choice for ancillary and raw
materials for the GMP-compliant manufacturing of cellular products. It includes cell culture media,
cytokines, cell culture bags, and other innovative tools for activation and expansion of cells.

CryoMACS® Freezing Products: Used for cryopreservation applications at ultra-low temperatures,

CryoMACS Freezing Bags are developed for quality, convenient handling, and safe cryopreservation.

TheraSorb™ Therapeutic Apheresis: Therapeutic Apheresis is a system for the selective removal of
pathogenic substances from patients’ plasma.

Executive team
Contact
Stefan Miltenyi
Miltenyi Biotec GmbH
President & Chief Executive Officer Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach
Dr. Boris Stoffel Germany
www.miltenyibiotec.com
Chief Executive Officer

Norbert Henschel
Chief Finance Officer